🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Sanofi Consumer Healthcare India Limited SANOFICONR NSEPHARMA

Healthcare · Drug Manufacturers - General · India
https://www.sanofi.com/en/india/consumer-healthcare
Company Profile ↓
₹3,357.00
-33.58% 1Y
Mkt Cap₹7,731.38 Cr
P/E29.07
P/B23.71
Div. Yield2.01%
52W High₹5,212.29
52W Low₹3,357.00
Book Value₹151.04
EPS (TTM)₹115.49

Company Overview

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 87.9%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 77.0%.

Consistent Profit Growth

Net profit has compounded at 20.7% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 27.0% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 29.1, below the sector median of 36.4.

Healthy Margins

Maintains a net profit margin of 28.0%.

Recent Developments

  • Dec 2025 Revenue of ₹878.00 Cr (+22.6% YoY); net profit ₹240.10 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +6.7%, earnings +13.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 27.0%, profit CAGR 20.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:27.01%
1 Year:6.70%

Compounded Profit Growth

5 Years:20.67%
1 Year:13.30%

Stock Price Performance

1 Year:-33.58%
6 Months:-25.73%
3 Months:-26.65%
1 Month:-16.77%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 0% of range
₹3,357.00 ₹5,212.29
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)14.46 · Oversold
Price Performance
1M-16.77%
3M-26.65%
6M-25.73%
1Y-33.58%
Valuation vs Sector

P/E of 29.07 is below the sector median of 36.43 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 87.9%.
  • Healthy ROCE of 77.0%.
  • Excellent profit margin of 28.0%.
  • Compounding revenue at 27.0% over 5 years.
  • Profit CAGR of 20.7% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading 35.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).
  • RSI at 14 suggests oversold conditions.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
29.07
Industry PE
36.43
Forward P/E
25.07
PEG Ratio
-
Book Value
₹151.04
Price to Book
23.71
P/S
8.70
EV/EBITDA
22.59
Dividend Yield
2.01%

Growth (CAGR)

Revenue 5Y
27.01%
Profit 5Y
20.67%
Revenue (YoY)
6.70%
Earnings (YoY)
13.30%

Profitability & Returns

ROCE
77.02%
ROE
87.95%
ROA
37.63%
Profit Margin
28.01%
Op Margin
36.49%
Gross Margin
74.14%
EPS (Latest Qtr)
₹29.87
EPS (TTM)
₹115.49

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
1.65
Current Ratio
2.03
Debt
₹20.80 Cr
Total Assets
₹706.40 Cr
Current Assets
₹663.40 Cr
Working Capital
₹365.90 Cr

Ownership

Promoter Holding
72.52%
Chg in Prom Hold
1.06%
FII / Inst Holding
18.37%
Chg in FII Hold
-1.25%

Financial Snapshot

Enterprise Value
₹7,731.38 Cr
Total Revenue (TTM)
₹949.80 Cr
EBITDA
₹346.40 Cr
Free Cash Flow
₹391.66 Cr
Operating Cash Flow
₹266.50 Cr
Shares Outstanding
₹2.30 Cr
Gross Margin
74.14%
Payout Ratio
64.93%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SANOFICONR Sanofi Consumer Healthcare India Limited NSEPHARMA 3,357.00 29.07 ₹7,731.38 Cr 2.01% 77.02% 87.95% 27.01% 20.67%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,745.10 34.62 ₹4.19 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,190.00 83.58 ₹2.44 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,553.80 72.74 ₹1.73 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,117.30 24.90 ₹1.11 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 631.35 164.41 ₹1.09 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,600.00 52.32 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,012.50 99.48 ₹1.09 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,314.00 31.51 ₹1.06 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue 172.60 Cr220.90 Cr233.90 Cr251.00 Cr229.20 Cr235.70 Cr
Cost of Revenue 38.80 Cr61.20 Cr61.80 Cr68.30 Cr56.20 Cr56.30 Cr
Gross Profit 133.80 Cr159.70 Cr172.10 Cr182.70 Cr173.00 Cr179.40 Cr
Operating Expenses 71.80 Cr92.50 Cr90.40 Cr96.30 Cr87.40 Cr93.40 Cr
Operating Income 62.00 Cr67.20 Cr81.70 Cr86.40 Cr85.60 Cr86.00 Cr
EBITDA 69.20 Cr82.40 Cr88.00 Cr94.40 Cr94.40 Cr95.60 Cr
Interest Expense 40.00 L50.00 L60.00 L50.00 L50.00 L40.00 L
Pretax Income 66.80 Cr78.90 Cr84.10 Cr90.50 Cr90.70 Cr91.90 Cr
Tax Provision 16.80 Cr18.20 Cr21.20 Cr24.00 Cr22.90 Cr23.10 Cr
Net Income 50.00 Cr60.70 Cr62.90 Cr66.50 Cr67.80 Cr68.80 Cr
Diluted EPS 21.6926.3627.3128.8729.4429.87

Profit & Loss (Annual)

Figures in INR.

Metric Dec 2023Dec 2024Dec 2025
Revenue 544.30 Cr716.20 Cr878.00 Cr
Cost of Revenue 194.00 Cr228.80 Cr279.80 Cr
Gross Profit 350.30 Cr487.40 Cr598.20 Cr
Operating Expenses 133.10 Cr221.20 Cr300.80 Cr
Operating Income 217.20 Cr266.20 Cr297.40 Cr
EBITDA 221.30 Cr255.30 Cr334.10 Cr
Interest Expense 20.00 L4.00 Cr2.10 Cr
Pretax Income 219.30 Cr246.80 Cr320.30 Cr
Tax Provision 54.40 Cr65.80 Cr80.20 Cr
Net Income 164.90 Cr181.00 Cr240.10 Cr
Diluted EPS 71.6078.59104.27

Balance Sheet (Annual)

Figures in INR.

Metric Dec 2023Dec 2024Dec 2025
Total Assets 345.40 Cr431.30 Cr547.00 Cr
Current Assets 335.20 Cr391.70 Cr494.30 Cr
Cash & Equivalents 1.60 Cr326.90 Cr374.80 Cr
Inventory 96.60 Cr40.90 Cr61.90 Cr
Receivables 31.60 Cr13.70 Cr29.60 Cr
Total Liabilities 137.80 Cr158.30 Cr163.00 Cr
Current Liabilities 129.90 Cr130.60 Cr128.40 Cr
Long Term Debt ---
Total Debt 020.30 Cr24.80 Cr
Total Equity 207.60 Cr273.00 Cr384.00 Cr
Shares Outstanding 2.30 Cr2.30 Cr2.30 Cr

Cash Flows (Annual)

Figures in INR.

Metric Dec 2023Dec 2024Dec 2025
Operating Cash Flow -40.00 L439.00 Cr174.80 Cr
Investing Cash Flow 01.90 Cr7.60 Cr
Financing Cash Flow 2.00 Cr-115.60 Cr-134.50 Cr
Capital Expenditure -4.00 Cr-9.90 Cr-7.60 Cr
Free Cash Flow -4.40 Cr429.10 Cr167.20 Cr
Net Change in Cash 1.60 Cr325.30 Cr47.90 Cr

Ratios (Annual)

Figures in %.

Metric Dec 2023Dec 2024Dec 2025
Gross Margin % 64.4%68.1%68.1%
Operating Margin % 39.9%37.2%33.9%
Net Margin % 30.3%25.3%27.3%
ROE % 79.4%66.3%62.5%
ROCE % 100.8%88.5%71.0%

Shareholding Pattern

Insiders
72.52%
Institutions
18.37%
Public Float
66.86%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SANOFICONR

Google News Mon, 15 Jun 2026

Is It Worth Considering Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR) For Its Upcoming Dividend? - Simply Wall Street

<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxQcjQyVngyQk82d01ILU0zR3Bad2RxQjhvRFROZWhTUkNlQ0ZNZjFNdmhMZUFpWHE4WkpYT3ZuOVZfdWY3Z05TRktoRkgxYzJmYWxkS1ZGMmtQMUY3YnBrSnV3TWpjVXdwanN6U1BuVjRvWnVsU2Y0Q0xsWWNRcFNDSzBsNTVwZVY2bjduRH…

Google News Fri, 16 Oct 2026

Sanofi Consumer Healthcare India (SANOFICONR) Share Price Near 52-Week Low on Weak Price Action - Univest

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdm1UZFhkTFg1X0d6TkhpeGNLTC12T1kyQmdfQ3VkeHhnaUwtenNBbnc0c2hJMmlrRjhmbUZZLTg3ZHYtM3IxeVlMaDZzbzA0MkRIMW04VVhTZkFpRVo5LTZta2xQNjdEUzlzdjFzY2FLbDI3b0ZhaDdxbExKYllaMlZ2OWpiSUVyNWcwUV…

Google News Fri, 25 Sep 2026

Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 cr - HDFC Sky

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPZjV5dHBERmZ1cGt5UWI1VTJHUzFUdFl1dmxORkRrZ1luZUVTbU1la1JPQU5pMW1wLU1uWThadDNqQlNFWldRZ1VKc3Z6c2VNZE53ZDFNRmluSTFEdlNoMUx3WE9nMFlIWlIzQ2twQ1JhWXhDOVlBdmltSE13a1E3cW1SMW5iUElPdjY3UF…

Google News Wed, 06 Aug 2025

SANOFICONR Stock Price and Chart — NSE:SANOFICONR - TradingView

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBYWmprVy1YTmVRTzNlTXp5WU5qRmx6VU0zSGFHeEppVmx3aUdYUDhSVTFMSTlpaG41WFdtMkNwdmRRS3cxQnA5dkJrVUV5VHhLTXpjaGNVNHU0dHhIbkFQMA?oc=5" target="_blank">SANOFICONR Stock Price and Chart — NS…

Google News Fri, 12 Dec 2025

Sanofi Consumer Healthcare India Ltd - Equitypandit

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE02ZjBLa2FGTWVSdkNMbDBZcGJlTFZBYWtheEFLN0tuYS0zcnlLMU1RTUhzdFV0TkpSeGZmNzNIVnl5SEpCdndJb2xZckZ5bmhhdlJNbXA1bHFSU1JwODI2TVUwQ2s5Zw?oc=5" target="_blank">Sanofi Consumer Healthcare In…

Google News Mon, 28 Sep 2026

Sanofi Consumer Healthcare India Q1 2026 Earnings: 22.59% Revenue Growth Despite Modest Stock Dip - Earnings Outlook Update - https://www.siam.in/

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxNb0IxeFZ4Nk5KTU9GWDZDVm56YTdvUmwtbUhObXFxdENGdzJrZXVYMjhHMVo4SExYRUNHMXZyQzNUcHZ3ajdqUTVYSDJ4a1ZPSnRQMDdQdU5PN0dMVG5lMUJsZGZMYTVXeW8yMWhFcGFEQnYyMUptTTQ2RTF3LWRTeU1Rb0l2cmlxUXdXZU…

SANOFICONR — Frequently Asked Questions

What is the current share price of Sanofi Consumer Healthcare India Limited (SANOFICONR)?

As of 2026-10-23 04:58 IST, Sanofi Consumer Healthcare India Limited (SANOFICONR) trades at ₹3,357.00 on NSE. Its 52-week range is ₹3,357.00 to ₹5,212.29.

What is the market capitalisation of SANOFICONR?

Sanofi Consumer Healthcare India Limited (SANOFICONR) has a market capitalisation of ₹7,731.38 Cr on NSE.

What is the P/E ratio of SANOFICONR?

SANOFICONR trades at a trailing price-to-earnings (P/E) ratio of 29.07. The industry average P/E is 36.43. Its price-to-book (P/B) ratio is 23.71.

Does SANOFICONR pay a dividend?

Sanofi Consumer Healthcare India Limited (SANOFICONR) currently offers a dividend yield of 2.01%.

What is the return on equity (ROE) of SANOFICONR?

SANOFICONR has a return on equity (ROE) of 87.95%. Its return on capital employed (ROCE) is 77.02%.

Is SANOFICONR a good stock to buy?

This page provides a data-driven analysis of Sanofi Consumer Healthcare India Limited (SANOFICONR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space